Qiyan Lin

USPTO Granted Patents = 11 (Patent Applications = 8)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 9.0

ph-index = 5

Forward Citations = 214(Granted Patents)

Company Filing History:

Incyte Holdings Corporation

patents

1 out of 234

Bristol-myers Squibb Pharma Company

patents

where one patent can have more than one assignee

Years Active: 2004-2024

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12084443 - Process of preparing a PD-1/PD-L1 inhibitor (2024-09-10),

2. 12043614 - Salts of a Pim kinase inhibitor (2024-07-23),

3. 12024522 - Salts and processes of preparing a PI3K inhibitor (2024-07-02),

4. 11780836 - Process of preparing a PD-1/PD-L1 inhibitor (2023-10-10),

5. 11505540 - Salts of a Pim kinase inhibitor (2022-11-22),

6. 11207302 - 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase (2021-12-28),

7. 9908888 - Processes for preparing pyrazolyl-substituted pyrrolo[2,3-d]pyrimidines (2018-03-06),

8. 9000161 - Processes for preparing JAK inhibitors and related intermediate compounds (2015-04-07),

9. 8796319 - 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase (2014-08-05),

10. 8410265 - Processes for preparing JAK inhibitors and related intermediate compounds (2013-04-02),

11. 6825210 - Tricyclic compounds useful as HIV reverse transcriptase inhibitors (2004-11-30),

Title: Qiyan Lin: Innovator in Pharmaceutical Chemistry

Introduction

Qiyan Lin is a prominent inventor based in Newark, DE (US), known for his significant contributions to pharmaceutical chemistry. With a total of 11 patents to his name, he has made remarkable advancements in the field of drug development, particularly in the treatment of cancer and infectious diseases.

Latest Patents

Among his latest patents is a process for preparing a PD-1/PD-L1 inhibitor. This invention relates to the synthesis of a compound that is useful in treating various diseases, including cancer. Another notable patent involves the salt forms of a Pim kinase inhibitor, which is also aimed at addressing cancer-related conditions. These innovations highlight his commitment to developing effective therapeutic solutions.

Career Highlights

Qiyan Lin has worked with notable companies such as Incyte Corporation and Incyte Holdings Corporation. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects that have the potential to impact patient care significantly.

Collaborations

Throughout his career, Qiyan Lin has collaborated with talented individuals, including Jiacheng Zhou and Pingli Liu. These partnerships have fostered an environment of innovation and creativity, leading to the successful development of new pharmaceutical compounds.

Conclusion

Qiyan Lin's contributions to the field of pharmaceutical chemistry through his patents and collaborations underscore his role as a leading inventor. His work continues to pave the way for advancements in medical treatments, particularly in oncology and infectious disease management.

This text is generated by artificial intelligence and may not be accurate.